Manulife (Manufacturers Life Insurance)
TNGX icon

Manulife (Manufacturers Life Insurance)’s Tango Therapeutics TNGX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.26M Buy
108,218
+75,876
+235% +$1.06M ﹤0.01% 1447
2025
Q4 		$287K Buy
32,342
+9,648
+43% +$83.1K ﹤0.01% 2376
2025
Q3 		$191K Sell
22,694
-6,111
-21% -$41.4K ﹤0.01% 2600
2025
Q2 		$147K Buy
28,805
+9,367
+48% +$23.2K ﹤0.01% 2659
2025
Q1 		$26.6K Buy
19,438
+142
+0.7% +$349 ﹤0.01% 2880
2024
Q4 		$59.6K Buy
19,296
+69
+0.4% +$320 ﹤0.01% 2919
2024
Q3 		$148K Sell
19,227
-10,284
-35% -$98.1K ﹤0.01% 2763
2024
Q2 		$253K Buy
29,511
+2,218
+8% +$17.1K ﹤0.01% 2499
2024
Q1 		$217K Buy
27,293
+9,213
+51% +$98.8K ﹤0.01% 2560
2023
Q4 		$179K Hold
18,080
– – ﹤0.01% 2665
2023
Q3 		$204K Buy
+18,080
New +$110K ﹤0.01% 2595
2023
Q2 		– Sell
-19,106
Closed -$75.5K – 3049
2023
Q1 		$75.5K Hold
19,106
– – ﹤0.01% 2802
2022
Q4 		$139K Sell
19,106
-1,206
-6% -$8.48K ﹤0.01% 2709
2022
Q3 		$73.5K Sell
20,312
-824
-4% -$3.52K ﹤0.01% 2877
2022
Q2 		$95.7K Buy
+21,136
New +$128K ﹤0.01% 2921

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s TNGX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Tango Therapeutics (TNGX) stake by 235% in Q1 2026, buying an estimated $1.06M and bringing the position to 108,218 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1447.

Manulife (Manufacturers Life Insurance) first reported a position in TNGX in Q2 2022 and has held it in 15 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 108,218 shares of Tango Therapeutics worth $2.26M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 75,876 Tango Therapeutics shares in Q1 2026, an estimated $1.06M.
  • Tango Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #1447 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Tango Therapeutics in Q2 2022 and has held it in 15 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.